Overall, loss of Gdf6 function led to an acceleration of disease progression in this ALS animal model, as measured by longevity, integrity of neuromuscuslar junctions, muscle endurance and muscle strength. Here, GDF6 is linked to amyotrophic lateral sclerosis.